1/22/2013

Myocardial perfusion SPECT has seen double-digit growth in the U.S. for the past 15 years in terms of procedure volume, but there is still a need to address certain limitations with cardiac SPECT to boost its clinical value, according to this article. Experts say reducing the method's acquisition time, increasing adoption of SPECT/CT and developing more SPECT-specific tracers are key to moving forward. Experts believe improving the modality's acquisition time would lead to advantages in terms of reimbursement, image quality and management of patients and health care staff. The increasing number of obese and aging patients needing cardiac SPECT imaging could be drivers of growth for the modality.

Related Summaries